UNSPSC 41141950: Cyclic amp test system

In this classification, Cyclic amp test system connotes a device used to measure Cyclic amp levels. US FDA regulates Cyclic amp test system under 21 CFR 862.1230 and under FDA product code CHO.

UNSPSC 41141950 Cyclic amp test system (Commodity) covers forensic and clinical laboratory reagents and testing kits used by state and local public-health and law-enforcement agencies for substance analysis, pathogen detection, and method validation. State and local governments soliciting under this code are purchasing immunoassay reagent kits for drug screening, certified reference materials (drug standards) for forensic laboratory validation and evidentiary analysis, and specialized testing systems for disease vectors—work performed by state departments of public safety, health and human services, law enforcement, county forensic laboratories, and special-purpose lab facilities. The code encompasses both consumable reagent supplies and associated test equipment, with jurisdictions typically requiring vendor compliance with ISO/IEC accreditation standards, DEA licensing where controlled substances are involved, and detailed certificates of analysis or product specifications.

Texas and Florida dominate recent activity under this code. The Texas Department of Public Safety posted an IFB on July 9, 2026 (due July 23, 2026) for Direct ELISA immunalysis reagent kits covering 12 substance-analysis line items including cannabinoids, opiates, amphetamines, and benzodiazepines for the Crime Lab Division, with one-year term and optional six-month extension. Pinellas County, Florida, in partnership with the Florida Department of Law Enforcement, issued an Invitation to Quote on April 23, 2026 for 131 line items of certified drug reference standards meeting ISO/IEC 17025:2017 accreditation with purity exceeding 97%, funded through the Paul Coverdell Forensic Sciences Improvement Act Program at $72,126.85 total, with preference extended to Pinellas County-certified SBEs. The Texas Health and Human Services Commission, on behalf of the Department of State Health Services, conducted a competitive IFB (HHS0016902v2, due January 29, 2026) for QIAxcel and QIAamp DNA screening kits for routine PCR evaluation at the state laboratory, with historical spend of $25,050–$30,000 in fiscal year 2025 and contract term through August 31, 2026 plus optional one-year extension. The Illinois Department of Financial and Professional Regulation's Centralized Maintenance Services established a joint purchase master contract (May 2026) for RAMP mosquito testing equipment and West Nile Virus and Dengue test kits through sole-source award to ADAPCO, LLC, designed to serve city, county, state, and federal agencies nationwide.